Home > Insider Trading > Filing (0001267273-13-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
791908	Xoma Corp	XOMA	Pharmaceutical Preparations (2834)	942756657

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267273	Fred Kurland	C/O Xoma Corporation 2910 Seventh Street Berkeley CA 94710	Cfo & Vp Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2013-08-14	19,064	$0.00	32,549	No	4	M	Direct
Common Shares	Disposition	2013-08-14	7,498	$3.86	25,051	No	4	S	Direct
Common Shares	Disposition	2013-08-15	13,231	$0.00	11,820	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	G	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Restricted Stock Units	Disposition	2013-08-14	19,064	$0.00	19,064	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
38,127		2015-08-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	17,396	Indirect	by 401(k)
Common Shares	5,000	Indirect	by Trust

Footnotes

Non discretionary open market sale of shares to satisfy the minimum amount of taxes required to be withheld in connection with the vesting of Restricted Stock Units pursuant to the award.
This transaction was executed in multiple trades ranging at prices from $3.86 to $3.94.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Mr. Kurland has gifted 13,231 shares to his daughter and son-in-law, jointly. They do not reside with Mr. Kurland, and Mr. Kurland disclaims any beneficial interest in the shares upon transfer.
These restricted stock units are scheduled to vest in substantially equal installments annually over three years, with the first installment vesting on August 14, 2013.